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Abstract
Background: Diagnosis of upper urinary tract infections 
(UTI) is challenging. We evaluated the analytical and 
diagnostic performance characteristics of renal tubular 
epithelial cells (RTECs) and transitional epithelial cells 
(TECs) on the Sysmex UF-5000 urine sediment analyzer.
Methods: Urinary samples from 506 patients presenting 
with symptoms of a UTI were collected. Only samples for 
which a urinary culture was available were included. Ana-
lytical (imprecision, accuracy, stability and correlation 
with manual microscopy) and diagnostic performance 
(sensitivity and specificity) were evaluated.
Results: The Sysmex UF-5000 demonstrated a good ana-
lytical performance. Depending on the storage time, 
storage conditions (2–8 °C or 20–25 °C) and urinary pH, 
RTECs and TECs were stable in urine for at least 4 h. Using 
Passing-Bablok and Bland-Altman analysis, an acceptable 
agreement was observed between the manual and auto-
mated methods. Compared to TECs, RTECs demonstrated 
an acceptable diagnostic performance for the diagnosis of 
upper UTI.
Conclusions: While TECs do not seem to serve as a helpful 
marker, increased urinary levels of RTECs add value in the 
diagnosis of upper UTI and may be helpful in the discrimi-
nation between upper and lower UTIs.
Keywords: automated urinary sediment analyzer; renal 
tubular epithelial cells; urinary tract infections.
Introduction
Differentiation between lower and upper urinary tract 
infections (UTI) is of paramount clinical importance, for 
which clinicians often have to rely on clinical symptoms. 
However, in adults and children, clinical criteria do not 
allow a 100% discrimination between both pathologies 
[1, 2]. Also, current laboratory methods do not always 
allow a clear-cut distinction between upper UTI and 
lower UTI (LUTI). Microbiological culture is not helpful in 
this respect as it does not provide information regarding 
the localization of the infection. Therefore, differentiat-
ing LUTI from upper UTI remains a diagnostic challenge 
in modern urinalysis. Urine sediment analysis can be 
helpful: the presence of leukocyte casts in the urine sedi-
ment is suggestive of an upper UTI, but its diagnostic 
sensitivity remains low [3]. Specific urinary proteins (e.g. 
α1-microglobulin) are established markers of tubular func-
tion, which have been shown to be helpful to some extent 
[4]. However, these markers may not be available in every 
routine clinical laboratory.
The Sysmex UF-5000 (Sysmex Corporation, Kobe, 
Japan) represents the newest generation of urinary par-
ticle analyzers, designed for automated urine sediment 
and body fluid analysis. This third-generation fluores-
cence flow cytometry analyzer for urinalysis offers the 
enhanced possibility to accurately count and differen-
tiate a broad variety of urinary cells. The instrument is 
able to differentiate epithelial cells into squamous (SEC), 
transitional (TECs) and renal tubular epithelial cells 
(RTECs). RTECs along with TECs line the urinary tract, 
originate from the proximal or distal urine segments and 
therefore have a diagnostic potential [5], whereas high 
SEC counts might point toward contaminated urine and 
add only little diagnostic value. RTECs are specific for 
the presence of tubular damage and their detection in 
a urinary sample could allow early recognition of renal 
damage when other kidney function parameters are 
still normal [5, 6]. On the contrary, TECs are markers of 
ureteral damage related to the presence of an infection, 
kidney stones or invasive procedures [5]. As these types 
of cells may differ in morphological presentation, they 
are a diagnostic challenge in modern clinical urinalysis 
laboratories [6].
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The aim of the present study was to explore the analyt-
ical performance and diagnostic value of RTECs and TECs 
in a cohort of well-documented patients presenting with 
symptoms of a UTI. In particular, we aimed to determine 
the value of RTECs and TECs for the diagnosis of upper 
UTI. Furthermore, we wanted to compare the diagnostic 
performance of RTECs and TECs with that of some estab-
lished upper UTI markers (α1-microglobulin, pathological 
casts, γ-glutamyl transpeptidase [GGT] activity).
Materials and methods
Patient population
The total population consisted of 506 patients (median age: 58 years 
[range: 18–97 years]; males: n = 237; females: n = 269) with a suspicion 
of a UTI and for whom a midstream urine sample for test strip and 
sediment analysis was sent to the clinical laboratory of the Ghent 
University Hospital. Based on the final diagnosis made by the clini-
cian, patients were retrospectively categorized into upper UTI (pyelo-
nephritis [n = 73], urosepsis [n = 32] and renal cystic infection [n = 2]), 
LUTI (cystitis [n = 35] and prostatitis [n = 12]) and 352 patients without 
UTI were categorized as disease controls. The main reasons for per-
forming urine sediment analysis were suspected clinical symptoms 
of a UTI (pollakisuria, dysuria, abdominal or flank pain, fever chills, 
etc.). Only patients with a proven microbiological UTI were included. 
A summary of the patient characteristics along with the RTEC and TEC 
count is presented in Table 1. The exclusion criteria were an unclear 
diagnosis, the inability to collect enough urine and an age <18 years.
Urine samples were collected by the aspiration technique using 
Sarstedt Monovette urinary collection tubes (Sarstedt, Numbrecht, 
Germany) and were processed within 2–4 h after arrival in the labo-
ratory. Test strip analysis on a Sysmex UC-3500 analyzer (Sysmex, 
Kobe, Japan) [7] was carried out before flow cytometry analysis on the 
Sysmex UF-5000 (Sysmex, Kobe, Japan). After microscopic analysis, 
urinary chemistry tests (see further) were determined.
The study was performed with the full respect for individuals’ 
rights to confidentiality and in accordance with procedures super-
vised by local authorities responsible for ethical research (Belgian 
registration number of ethical approval: B670201837110).
Urine particle analysis using UF-5000 and microscopic 
analysis
Measurement of RTECs and TECs was performed using the Sysmex 
UF-5000 (Sysmex, Kobe, Japan). The UF-5000 is able to recognize, 
count and classify cells by analyzing forward scatter light, side scatter 
light, side fluorescent light and the depolarized side scattered light of 
stained particles. Depolarized side scattered light was introduced to 
improve the sensitivity of crystals and to better discriminate red blood 
cells (RBCs) from crystals. The principle is based on a 488-nm blue 
laser flow cytometry. The UF-5000 measures urinary conductivity and 
categorizes the particles based on their size, intracellular structure and 
staining characteristics. The signals are displayed in scattergrams and 
histograms and the results are given as counts per μL as well as counts 
per high power field (HPF) [8]. The UF-5000 automatically detects and 
counts RBCs, non-lysed RBCs, white blood cells (WBCs), WBC clumps, 
bacteria, yeast-like cells, crystals, RTECs, TECs, sperm cells and (hya-
line and pathological) casts. Urinary particles that cannot be classified 
into one of the former categories are counted as “other cells”.
Following the analysis on the automated urine sediment ana-
lyzer, microscopic identification and counting were performed by 
phase-contrast microscopy on uncentrifuged urine samples using 
disposable Uriglass counting chambers (A. Menarini Diagnostics, 
Florence, Italy) by two expert laboratory technicians blinded to the 
results of the Sysmex UF-5000. Each 1-μL chamber is divided into 10 
large squares. Each square corresponds to a volume of 0.1 μL and is 
subdivided into 16 small squares. RTECs and TECs were counted in 5 
x 16 squares, and the results are expressed as the number of particles 
per μL of urine.
Biochemical investigations
Following the urinary sediment analysis, biochemical investigations 
were also performed. Total protein was determined on all samples by 
a pyrogallol red-molybdate method (Instruchemie BV, Delfzijl, The 
Netherlands) [9]. Urinary α1-microglobulin was assayed immunotur-
bidimetrically using Roche reagents (Mannheim, Germany). Urinary 
GGT activity was measured according to the method of Szasz [10] 
using commercial reagents from Abbott. Urinary creatinine and uri-
nary urea were also determined using Abbott commercial reagents. 
All analyses were performed on the Abbott Alinity C analyzer (Abbott 
Diagnostics, Wiesbaden, Germany).
Table 1: Overview of the patient characteristics and RTEC and TEC counts (/μL) of the different patient groups.
Final diagnosis n Men/women, n/n Age, years (range)a RTECs, /μLb TECs, /μLb
Upper urinary tract infection
 Urosepsis 32 19/13 71 (27–93) 5.5 (3.3–10.6) 0.6 (0.1–1.3)
 Pyelonephritis 73 19/54 59 (18–97) 9.8 (6.3–13.6) 0.6 (0.3–1.3)
Lower urinary tract infection
 Cystitis 35 6/29 58 (18–95) 1.4 (0.3–4.3) 0.3 (0.1–0.9)
 Prostatitis 12 12/0 69 (40–85) 1.5 (0.7–2.1) 0.7 (0.0–2.1)
Non-urological/non-nephrological patients 354 181/173 55 (18–94) 1.3 (0.4–2.6) 0.1 (0.0–0.3)
aAge is presented as years (range). bThe value within brackets indicates the interquartile range (IQR). RTECs: renal tubular epithelial cells; 
TECs: transitional epithelial cells.
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Microbiological culture
Biplates with Tryptic Soy Agar (TSA) + 5% sheep blood and MacCo-
nkey agar (Becton Dickinson, Cockeysville, MD, USA) were used for 
chairside inoculation of 1 μL of freshly voided urine, and incubated 
upon arrival at 35 °C ambient atmosphere overnight and for another 
24 h. Interpretation is done after 24 and 48 h of incubation. All sus-
pect colony types were identified using matrix-assisted laser desorp-
tion/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) 
(Microflex LT, Bruker, Billerica, MA, USA). Criteria for positivity of a 
urine culture were in accordance with the European Federation for 
Urinalysis guidelines [11].
Statistical analysis
Imprecision of RTECs and TECs on the UF-5000 was assessed using 
three patient samples (low, medium and high level). Intra-run impre-
cision was determined by measuring each sample 10 times in the 
same run. As the stability of RTECs is limited, only within-run impre-
cision was assessed. Bias was determined by calculating the % dif-
ference between the mean RTEC value of the intra-run imprecision 
experiment and the target value. This target value was determined 
by manually counting the number of RTECs and TECs. The total error 
(TE) was calculated using the formula: TE = bias + 1.65 * (intra-run 
imprecision [%]).
The stability of RTECs and TECs at two different storage condi-
tions (room temperature [20–25 °C, 24  h] and refrigerator [2–8 °C, 
24  h]) on 10 different samples was determined (RTEC: mean con-
centration: 21.7/μL, range: 9.3–38.9/μL; TEC: mean concentration: 
17.4/μL, range: 5.8–55.4/μL). Samples were determined 2, 4, 6, 8, 10, 
12, 16 and 24 h after the initial measurement. Allowable TE internal 
laboratory criteria for SECs (i.e. 30%) were used as criterion for sig-
nificant deviation with respect to the initial value. RTEC and TEC con-
centrations were determined using the UF-5000.
For analytical method comparison, Bland-Altman plots, Pass-
ing-Bablok regression analysis and Spearman’s rank correlation coef-
ficients were determined for both assays.
Differences in RTEC count between (sub)groups were assessed 
for significance using the Mann-Whitney U test. p-Values <0.05 were 
considered statistically significant. Receiver operating characteris-
tic (ROC) curve analysis and areas under the ROC curve (AUC) were 
calculated to evaluate the diagnostic accuracy of the different para-
meters measured. Sensitivities and specificities were determined 
with the clinical diagnosis. Optimal cut-offs were defined as cut-off 
values with the highest sum of sensitivity and specificity, based on 
ROC curve analysis.
Statistical analysis was performed using the MedCalc software 
(version 15.6.1., Mariakerke, Belgium).
Results
Analytical performance
Imprecision, bias, total error and stability
Within-run imprecision ranged from 6.0 to 10.6% and 5.0 
to 12.9% for RTECs and TECs, respectively. The bias rela-
tive to the manual count ranged from −2.6 to 6.5% and 
−5.9 to 15.2% for RTECs and TECs, respectively. The calcu-
lated TE was acceptable and ranged from 12.5 to 24.0% for 
RTECs and 9.8 to 36.5% for TECs. A summary is presented 
in Table 2.
We determined the stability of RTECs and TECs at 
both room temperature (20–25 °C) and in the refrigerator 
(2–8 °C) and found that the stability of both parameters 
depended on the pH of the urinary sample. RTEC and TEC 
counts in samples with a pH ≥7.5 were stable for maximum 
4 h at both room and refrigerator temperature. RTEC and 
TEC counts in samples with a pH <7.5 were stable for 8 h 
at room temperature. In the refrigerator, TEC counts were 
stable for 12  h and RTECs for 16  h. The results are pre-
sented in Figure 1.
Table 2: Analytical performance (imprecision, bias and total error) of RTECs and TECs on the Sysmex UF-5000.
Imprecision (within-run) Bias Total error
Mean, /μL SD, /μL CV, % Target % Deviation Results, % Criteria, %a
RTECs
 Low 5.6 0.6 10.6 6.0 6.5 24.0 50
 Medium 16.4 1.4 8.7 16.0 −2.4 16.8 30
 High 39.0 2.3 6.0 38.0 −2.6 12.5 30
TECs
 Low 2.5 0.3 12.9 3.0 15.2 36.5 50
 Medium 20.6 1.4 7.1 19.0 −5.9 17.7 30
 High 49.8 2.5 5.0 49.0 −1.6 9.8 30
SD, standard deviation; CV, coefficient of variation; RTECs, renal tubular epithelial cells; TECs, transitional epithelial cells. aSource criteria: 
internal laboratory criteria.
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Method comparison
Method comparison was performed on 504  samples. 
Passing-Bablok regression analysis between manual 
microscopic and automated RTEC counts revealed a 
proportional difference of approximately 4% (slope: 
0.96 [95% CI: 0.91–1.00]; intercept: −0.42 [95% CI: −0.50 
to −0.36]; R2: 0.972 [95% CI: 0.966–0.976]) (Figure 2A1). 
Using Bland-Altman analysis, a mean difference of −10.1 
RTEC cells/μL (95% CI: −16.0 to −4.2/μL) was obtained 
0
%
 D
iff
e
re
n
ce
 to
 th
e 
in
iti
al
 v
a
lu
e
%
 D
iff
e
re
n
ce
 to
 th
e 
in
iti
al
 v
a
lu
e
–80
–60
–40
–20
0
20
–80
–60
–40
–20
0
20
4 8
Time, h after initial measurement
RTEC TEC
12 16 20 24
pH: 5.5–7.0; 2–8 °C
pH: 5.5–7.0; 20–25 °C
pH: 7.5–9.0; 2–8 °C
pH: 7.5–9.0; 20–25 °C
pH: 5.5–7.0; 2–8 °C
pH: 5.5–7.0; 20–25 °C
pH: 7.5–9.0; 2–8 °C
pH: 7.5–9.0; 20–25 °C
0 4 8
Time, h after initial measurement
12 16 20 24
Figure 1: Overview of the stability of RTEC and TEC counts. 
Mean difference ranges (%) of renal tubular epithelial cell (RTEC) (A) and tubular epithelial cell (TEC) (B) counts stored for 24 h at 2–8 °C and 
at 20–25 °C. The mean difference to the initial value for the different RTEC and TEC counts is presented. The level of acceptance (30%) is 
shown as a dashed line. The error bars represent the 95% confidence interval.
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Figure 2: Method comparison of renal tubular epithelial cell (RTEC) and transitional epithelial cell (TEC) counts. 
Method comparison of RTEC and TEC counts with Passing-Bablok (A) and Bland-Altman (B) analysis of manual microscopy vs. Sysmex UF-5000.
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with limits of agreement (LOA) of −104.7 cells/μL (95% 
CI: −114.8 to −94.6) and 84.5 cells/μL (95% CI: 74.4–94.6) 
(Figure 2B1).
For TEC, no significant proportional or systemic dif-
ferences were obtained between manual and automated 
counts (slope: 1.00 [95% CI: 0.90–1.30]; intercept: 0.30 
[95% CI: 0.30–0.30]; R2: 0.980 [95% CI: 0.977–0.984]) 
(Figure 2A2). Bland-Altman analysis revealed a mean dif-
ference of −2.3 TEC cells/μL (95% CI: −8.1 to 3.6) with LOA 
of −51.1 (95% CI: −61.1 to −41.0) and 46.5 (95% CI: 36.5–
56.6) (Figure 2B2).
Correlation study
Multiple linear mixed model analysis revealed signifi-
cant correlations between RTECs and log-transformed 
GGT (β = 3.1865, standard error [SE] = 0.648, p < 0.0001), 
completed by log-transformed bacteria (β = 1.1091, 
SE = 0.207, p < 0.0001) and α1-microglobulin (β = 0.0269, 
SE = 0.007, p < 0.0001). The r2 value of the final model 
was poor (0.167). No significant correlations were 
obtained between TECs and the other measured urinary 
parameters.
Diagnostic performance
Among the study population, the prevalence of upper 
UTI was 21.1% (107/506). Quantitative data distribu-
tion showed that RTEC counts were significantly higher 
(p < 0.05) in patients with a final diagnosis of urosepsis 
and pyelonephritis compared to counts in patients diag-
nosed with cystitis and prostatitis (see Figure 3). On the 
contrary, no significant difference in TECs between the 
different subgroups was observed.
In our population, the diagnostic accuracy 
(expressed as AUC) for the parameters α1-microglobulin, 
bacteria, GGT, WBCs, RTECs, TECs and pathological casts 
on the Sysmex UF-5000  was found to be 0.735 (95% CI: 
0.694–0.773), 0.787 (95% CI: 0.748–0.821), 0.586 (95% 
CI: 0.541–0.629), 0.816 (95% CI: 0.779–0.849), 0.923 (95% 
CI: 0.897–0.945), 0.790 (95% CI: 0.752–0.825) and 0.751 
(95% CI: 0.711–0.788), respectively (see Figure  4). The 
AUCs were statistically significantly different (p < 0.05) 
between RTECs and α1-microglobulin, bacteria, GGT, 
pathological casts, TECs and WBCs. Statistically signifi-
cant differences in AUCs were also observed between 
α1-microglobulin and WBCs and pathological casts and 
WBCs (p-value <0.01). A summary of the diagnostic per-
formance of these parameters measured on the Sysmex 
UF-5000 in our study population is presented in Table 3. 
The same AUCs were demonstrated for RTECs and TECs 
counted by manual microscopy (data not shown).
The median conductivity and urinary creatinine con-
centrations of the samples in the study were 13.2 mS/cm 
(interquartile range [IQR]: 9.2–18.6 mS/cm) and 91.0 mg/
dL (IQR: 48.7–140.9  mg/dL), respectively. The obtained 
diagnostic performance (expressed as AUC) for RTECs 
corrected for conductivity and RTECs corrected for 
urinary creatinine (0.900 [95% CI: 0.867–0.927] and 0.905 
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Figure 3: Box-whisker plots representing renal tubular epithelial 
cell (RTEC) counts among the different clinical conditions.
Values falling outside the box-whisker plot are outliers.
Figure 4: Presentation of the receiver operating characteristic (ROC) 
curve comparison for the parameters α1-microglobulin, urinary 
bacterial count, white blood cells (WBCs), renal tubular epithelial 
cells (RTECs), tubular epithelial cells (TECs) and pathological casts.
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[95% CI: 0.872–0.931], respectively) was not significantly 
different compared to the AUC of RTECs (AUC: 0.911 
[95% CI: 0.880–0.936]), demonstrating that there is no 
added value when the results are corrected for dilution 
parameters.
Discussion
While SECs and TECs offer little useful information, we 
have demonstrated for the first time that RTECs can be 
regarded as an interesting supplemental parameter in 
the discrimination between upper UTI and LUTI. In line 
with previous studies [8, 12], our study showed that the 
Sysmex UF-5000 urine sediment analyzer is able to count 
the RTECs and TECs with an acceptable analytical perfor-
mance. These parameters were not available on earlier 
generations of urinary flow cytometers [3, 13, 14], catego-
rizing RTECs as “small round cells”. Compared to manual 
microscopy, a sensitivity and a specificity of 95% and 
75% for RTECs and 71% and 94% for TECs at a cut-off of 
3 and 5 cells/μL were reported, respectively [8]. Due to 
the improved categorization of urinary particles of the 
UF-5000, the discriminatory power of this new-generation 
urinary flow cytometer with respect to localization of UTI 
has much improved.
Multiple regression analysis revealed that RTEC values 
strongly correlated with bacterial and WBC counts, which 
are indicators of UTI. Similarly, a strong correlation was 
found between RTEC count and urinary α1-microglobulin 
concentration and GGT activity in urine. The latter two 
parameters have been previously described as indicators 
of upper UTI [3, 15].
In the past, different potential markers to discriminate 
between upper UTI and LUTI have been studied [16, 17]. 
Although urinary neutrophil gelatinase-associated lipoca-
lin (NGAL) concentrations were increased in patients with 
upper UTI and LUTI compared to the control group, a 
differentiation between upper UTI and LUTI using this 
marker was not possible [17]. As the proximal tubule is 
not mainly affected in upper UTI [18] and as kidney injury 
molecule-1 (KIM-1) represents especially an injury marker 
of the proximal tubule, urinary KIM-1 can also not be con-
sidered as a suitable marker for discriminating upper UTI 
from LUTI [16].
As expected [5], increased RTEC counts were observed 
in urine specimens from patients with upper urinary tract 
pathology. Inflammation is known to target TECs. Tubular 
cells have been implicated in the response to inflamma-
tory mediators in ischemic and septic renal damage [19]. Ta
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)
 
82
.2
 (7
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85
.8
)
 
72
.2
9 
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)
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 (6
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 (p
 < 
0.
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b In
di
ca
te
s s
ta
tis
tic
al
ly 
di
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 (p
 < 
0.
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); 
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 a
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g 
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ub
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; S
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 er
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r; 
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Cs
, t
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el
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; W
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te
 b
lo
od
 ce
lls
.
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We demonstrated that RTECs may add value in the dis-
crimination between upper UTI and LUTI. At a cut-off 
level of 3.1 cells/μL, which corresponds with the manufac-
turer’s set upper reference limit (0–3 cells/μL), we found 
a sensitivity and a specificity of 93.5% and 82.2%, respec-
tively. The diagnostic performance of RTECs in the differ-
entiation between upper UTI and LUTI exceeded by far the 
one of TECs.
In our previous study, α1-microglobulin proved to be a 
useful discriminator between upper UTI and LUTI [3, 20]. 
However in this study, comparative ROC analysis dem-
onstrated that the diagnostic utility of RTECs for detect-
ing upper UTI outperforms that of α1-microglobulin, GGT 
activity, leukocyturia and pathological casts. In accord-
ance with the findings of Penders et al. [3], we found that 
pathological casts showed a low specificity for localizing 
UTI. These findings could be attributed to the low number 
of casts usually found in urinary specimens and the dif-
ficult quantification of these urinary structures in urinary 
particle analysis [13, 21, 22].
Time between sampling and performance of the 
examination procedure is critical for the reliability of 
urinary test results [23]. Stability data are known for most 
usual urine sediment parameters [24], but lack for RTECs 
and TECs. We found that the stability of RTECs and TECs at 
room temperature is limited to 4 h. As most clinical labo-
ratories are able to process urinary samples for urinalysis 
immediately after arrival in the laboratory, this limited sta-
bility can be overcome. However, special attention should 
be paid to the pH dependent stability of RTECs and TECs, 
as a higher pH (pH > 7.5) decreases the RTEC and TEC sta-
bility with approximately 8 h. The same dependency has 
been observed for urinary casts and WBCs [25], which are 
also lost in alkaline urines. High urinary pH values may 
be observed in infections with urease-producing bacteria 
[25]. Cooling of the specimen at 2–8 °C improves the stabil-
ity of both parameters.
Although the inbuilt UF-5000 osmolality parameters 
may allow to correct for urinary dilution, the diagnos-
tic power of RTECs cannot further be improved by cor-
recting results using urinary conductivity and urinary 
creatinine. This could be explained by the fact that the 
stability of both parameters is, as urinary WBCs, affected 
by extremely diluted or concentrated specimens [25].
In conclusion, our study adds interesting information 
on the performance of some new parameters that recently 
have become available on a routine new generation urine 
sediment analyzer [26]. Along with the results of urinary 
microbiological culture and clinical evaluation, RTECs 
may be considered as an interesting supplemental analyte 
for differentiating upper UTI from LUTI.
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